Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.04.2022 | Case report

AZD-1222

Vaccine-induced immune thrombotic thrombocytopenia with massive cerebral venous sinus thrombosis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Mirandola L, et al. Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach. Neurological Sciences 43: 1499-1502, No. 3, Mar 2022. Available from: URL: http://doi.org/10.1007/s10072-021-05805-y Mirandola L, et al. Massive cerebral venous sinus thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 serum: case report of a successful multidisciplinary approach. Neurological Sciences 43: 1499-1502, No. 3, Mar 2022. Available from: URL: http://​doi.​org/​10.​1007/​s10072-021-05805-y
Metadaten
Titel
AZD-1222
Vaccine-induced immune thrombotic thrombocytopenia with massive cerebral venous sinus thrombosis: case report
Publikationsdatum
01.04.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-12431-9

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

AZD-1222

Case report

Spironolactone

Case report

Antineoplastics